Thursday, 24 May 2018
Latest news
Main » Zoetis Inc. (ZTS) EPS Estimated At $0.70 on May, 2

Zoetis Inc. (ZTS) EPS Estimated At $0.70 on May, 2

21 April 2018

The corporation has a market cap of US$41.64 Billion. The stock increased 1.23% or $2.19 during the last trading session, reaching $180.24. Following the transaction, the insider now owns 20,162 shares in the company, valued at approximately $1,707,923.02.

Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, February 15th. It has underperformed by 38.77% the S&P500. During the same quarter in the previous year, the firm posted $0.47 earnings per share. research analysts anticipate that Zoetis will post 3.04 earnings per share for the current fiscal year. (NYSE:ZTS) to report its quarterly earnings, according to RTT. The profit will be $339.58M for ZTS if $0.70 EPS becomes true. After $0.69 actual earnings per share reported by Zoetis Inc. for the previous quarter, Wall Street now forecasts 1.45% EPS growth. The stock decreased 0.51% or $0.43 during the last trading session, reaching $85.41. About 447,608 shares traded. ZTS outperformed by 40.13% the S&P500. "Buy" rating has 8, "Sell" are 0, while 6 are "Hold". Therefore 13% are positive. The stock now has a consensus rating of "Buy" and an average price target of $81.61. On Friday, February 16 the rating was maintained by Deutsche Bank with "Hold". On Thursday, December 21 the stock rating was maintained by Cantor Fitzgerald with "Buy". Jefferies has "Buy" rating and $9600 target. The firm earned "Neutral" rating on Monday, October 9 by Citigroup. FBR Capital maintained the shares of MTB in report on Tuesday, October 20 with "Mkt Perform" rating. Envestnet Asset Management Inc. now owns 134,904 shares of the company's stock valued at $9,719,000 after purchasing an additional 32,149 shares in the last quarter. Intl Flavors & Fragrance (NYSE:IFF) was reduced too. 429.52 million shares or 2.55% less from 440.74 million shares in 2017Q3 were reported. FLAHERTY LAUREN PATRICIA sold $396,643 worth of CA, Inc.

Investors sentiment increased to 1.07 in Q4 2017. Its the same as in 2017Q3. ZTS has also 495,323 shares volume. Manufacturers Life Insurance Company The reported 488,446 shares. Massmutual Tru Co Fsb Adv reported 0% stake. Private Harbour Investment Mngmt Counsel Limited Liability invested 2.2% of its portfolio in Zoetis Inc. Corporate insiders own 0.35% of the company's stock. Fuller And Thaler Asset Management Inc has 3,000 shs for 0% of their capital. (NASDAQ:CA). Engineers Gate Manager Lp reported 85,616 shares. (NASDAQ:CA) for 128,835 shares. Therefore 71% are positive. Magellan Midstream Partners L.P. had 68 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has "Buy" rating by Zacks on Thursday, September 17. The rating was maintained by Jefferies with "Buy" on Tuesday, August 15. (NYSE:ZTS) rating on Friday, February 16. Cowen & Co has "Buy" rating and $70.0 target. Wunderlich downgraded the stock to "Hold" rating in Monday, April 4 report. The firm earned "Buy" rating on Thursday, February 15 by Stifel Nicolaus. As per Friday, November 24, the company rating was downgraded by UBS. On Thursday, April 5 the stock of Zoetis Inc.

Investors sentiment increased to 1.13 in 2017 Q4. Craig Hallum maintained Zoetis Inc. Daiwa SB Investments Ltd. raised its stake in shares of Zoetis by 92.0% in the 4th quarter. Hillsdale stated it has 0.06% in Zoetis Inc. First Long Island Ltd holds 0.81% of its capital in Zoetis Inc. (NYSE:ZTS). Stifel Fincl Corp invested in 0.05% or 215,631 shs. 43,522 were accumulated by Pineno Levin And Ford Asset Mgmt. Usca Ria Ltd accumulated 6,233 shares or 0.05% of the stock. The company was upgraded on Monday, August 10 by Credit Suisse.

Btc Cap Mgmt has 49,101 shs for 0.61% of their capital. Sei Invests Com invested in 673,435 shs or 0.17% of the stock. (NYSE:ZTS) for 4 shares. (NYSE:ZTS). Plante Moran Advisors Limited Liability Company reported 765 shares stake. Its up 0.04, from 1.03 in 2017Q3. Shell Asset holds 0.03% or 9,270 shares. Pacad Invest reported 3,400 shares stake.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States and internationally. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. The return on equity ratio or ROE stands at 48.8 percent while most common profitability ratio return on investment (ROI) was 16 percent. The firm also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products.

Also, insider Heidi C. Chen sold 37,453 shares of the business's stock in a transaction dated Tuesday, February 20th. Jefferies maintained Zoetis Inc. It improved, as 34 investors sold ZTS shares while 251 reduced holdings. Brown Advisory Inc. lifted its position in shares of Zoetis by 2.1% during the fourth quarter.

Among 21 analysts covering Zoetis Inc (NYSE:ZTS), 14 have Buy rating, 0 Sell and 7 Hold.

Among 13 analysts covering Zoetis (NYSE:ZTS), 8 have Buy rating, 0 Sell and 5 Hold.